Aprea Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Aprea Therapeutics

11/08/2022 23:36

* Aprea Therapeutics Inc  APRE.OQ  reported a quarterly
adjusted
loss of 98 cents​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 37 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Aprea Therapeutics Inc's reported EPS for the quarter was
a loss
of $4.34​.
    * The mean earnings estimate of analysts had risen by
about 6.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Aprea Therapeutics Inc shares had risen by 32.8% this
quarter and lost 65.3% so far this year.
    * The company reported a quarterly loss of $98.26 million.
    * Wall Street's median 12-month price target for Aprea
Therapeutics Inc is $2.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 11
at 10:36 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.37          -0.98          Missed
 Mar. 31 2022      -0.38          -0.36          Beat
 Dec. 31 2021      -0.44          -0.36          Beat
 Sep. 30 2021      -0.45          -0.45          Met